Symbols / PTN $21.65 -3.05% Palatin Technologies, Inc.

Healthcare • Biotechnology • United States • ASE
PTN Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.

Stock Fundamentals
Scroll to Statements
Market Cap 38.36M Enterprise Value 25.44M Income -9.63M Sales 8.96M Book/sh 6.53 Cash/sh 8.17
Dividend Yield — Payout 0.00% Employees 29 IPO — P/E — Forward P/E -8.80
PEG 1.62 P/S 4.28 P/B 3.32 P/C — EV/EBITDA -2.06 EV/Sales 2.84
Quick Ratio 2.54 Current Ratio 2.76 Debt/Eq 3.04 LT Debt/Eq — EPS (ttm) -8.26 EPS next Y -2.46
EPS Growth — Revenue Growth — Earnings 2026-02-17 ROA -70.26% ROE -3.79% ROIC —
Gross Margin -40.24% Oper. Margin -63.16% Profit Margin -107.41% Shs Outstand 1.77M Shs Float 1.36M Short Float 10.17%
Short Ratio 12.59 Short Interest — 52W High 31.00 52W Low 2.00 Beta -0.15 Avg Volume 18.48K
Volume 4.30K Target Price $54.33 Recom None Prev Close $22.32 Price $21.64 Change -3.05%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$54.33
Mean price target
2. Current target
$21.65
Latest analyst target
3. DCF / Fair value
$-126.54
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$21.65
Low
$50.00
High
$60.00
Mean
$54.33

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-12-12 init Laidlaw & Co. — → Buy $60
2025-02-13 main HC Wainwright & Co. Buy → Buy $7
2025-02-07 reit HC Wainwright & Co. Buy → Buy $17
2024-12-19 reit HC Wainwright & Co. Buy → Buy $17
2024-11-25 reit HC Wainwright & Co. Buy → Buy $17
2024-11-04 reit HC Wainwright & Co. Buy → Buy $17
2024-10-31 reit HC Wainwright & Co. Buy → Buy $17
2024-10-24 reit HC Wainwright & Co. Buy → Buy $17
2024-06-20 reit HC Wainwright & Co. Buy → Buy $17
2024-06-12 reit HC Wainwright & Co. Buy → Buy $17
2024-05-15 reit HC Wainwright & Co. Buy → Buy $17
2024-05-08 reit HC Wainwright & Co. Buy → Buy $17
2024-05-02 reit HC Wainwright & Co. Buy → Buy $17
2024-02-28 main HC Wainwright & Co. Buy → Buy $17
2024-02-15 reit HC Wainwright & Co. Buy → Buy $70
2023-08-10 reit HC Wainwright & Co. Buy → Buy $70
2023-08-08 reit HC Wainwright & Co. Buy → Buy $70
2023-08-07 reit HC Wainwright & Co. Buy → Buy $70
2023-05-30 reit HC Wainwright & Co. Buy → Buy $70
2023-05-09 reit HC Wainwright & Co. — → Buy $70
News
RSS: Latest PTN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-24 WILLS STEPHEN T Chief Operating Officer — 565 $16.74 $9,461
2025-12-09 PRENDERGAST JOHN K. A. PH.D. Director — 2,600 $0.00 $0
2025-12-09 SPANA CARL Chief Executive Officer — 885 $0.00 $0
2025-12-09 WILLS STEPHEN T Chief Operating Officer — 770 $0.00 $0
2025-12-09 DUNTON ALAN WILLIAM Director — 2,000 $0.00 $0
2025-05-07 DE VEER ROBERT K JR Director — 100,000 $0.10 $10,180
2024-08-01 WILLS STEPHEN T Chief Operating Officer — 4,999 $1.65 $8,274
2024-07-15 MANNING ANTHONY M Director — 12,000 — —
2024-07-15 PRENDERGAST JOHN K. A. PH.D. Director — 16,000 — —
2024-07-15 SPANA CARL Chief Executive Officer — 112,201 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
0.00
-100.00%
4.49
-7.49%
4.85
+230.53%
1.47
Operating Revenue
0.00
-100.00%
8.88
-28.79%
12.46
+105.44%
6.07
Cost Of Revenue
0.00
-100.00%
0.10
-76.67%
0.42
+92.37%
0.22
Reconciled Cost Of Revenue
0.00
-100.00%
0.10
-76.67%
0.42
+92.37%
0.22
Gross Profit
0.00
-100.00%
4.39
-0.96%
4.44
+254.55%
1.25
Operating Expense
22.71
-34.50%
34.67
-8.57%
37.92
+0.22%
37.84
Research And Development
14.90
-33.49%
22.40
-1.02%
22.63
+6.11%
21.33
Selling General And Administration
7.81
-36.35%
12.27
-19.76%
15.29
-7.40%
16.51
Other Operating Expenses
—
—
-1.03
—
Total Expenses
22.71
-34.69%
34.77
-9.32%
38.34
+0.74%
38.06
Operating Income
-22.71
+25.00%
-30.28
+9.58%
-33.49
+8.48%
-36.59
Total Operating Income As Reported
-17.46
+22.39%
-22.50
+30.69%
-32.46
+11.29%
-36.59
EBITDA
-17.03
+42.02%
-29.38
-3.44%
-28.40
+21.19%
-36.04
Normalized EBITDA
-22.45
+26.72%
-30.64
+10.72%
-34.31
+5.89%
-36.46
Reconciled Depreciation
0.26
-23.64%
0.34
+17.60%
0.29
+127.63%
0.13
EBIT
-17.29
+41.81%
-29.72
-3.58%
-28.69
+20.67%
-36.17
Total Unusual Items
5.42
+331.21%
1.26
-78.75%
5.91
+1307.77%
0.42
Total Unusual Items Excluding Goodwill
5.42
+331.21%
1.26
-78.75%
5.91
+1307.77%
0.42
Special Income Charges
5.25
-32.56%
7.78
+657.49%
1.03
0.00
Other Special Charges
-2.12
—
-1.03
—
Net Income
-17.31
+41.80%
-29.74
-23.71%
-24.04
+33.60%
-36.20
Pretax Income
-17.31
+41.80%
-29.74
-3.57%
-28.71
+20.68%
-36.20
Net Non Operating Interest Income Expense
-0.02
+12.21%
-0.02
+14.49%
-0.02
+32.58%
-0.03
Interest Expense Non Operating
0.02
-12.21%
0.02
-14.49%
0.02
-32.58%
0.03
Net Interest Income
-0.02
+12.21%
-0.02
+14.49%
-0.02
+32.58%
-0.03
Interest Expense
0.02
-12.21%
0.02
-14.49%
0.02
-32.58%
0.03
Other Income Expense
5.42
+868.85%
0.56
-88.34%
4.79
+1042.00%
0.42
Other Non Operating Income Expenses
—
-0.70
+37.54%
-1.12
—
Gain On Sale Of Security
0.17
+102.57%
-6.53
-233.65%
4.88
+1063.07%
0.42
Tax Provision
—
0.00
+100.00%
-4.67
0.00
Tax Rate For Calcs
0.00
0.00
-100.00%
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
-100.00%
0.96
0.00
Net Income Including Noncontrolling Interests
-17.31
+41.80%
-29.74
-23.71%
-24.04
+33.60%
-36.20
Net Income From Continuing Operation Net Minority Interest
-17.31
+41.80%
-29.74
-23.71%
-24.04
+33.60%
-36.20
Net Income From Continuing And Discontinued Operation
-17.31
+41.80%
-29.74
-23.71%
-24.04
+33.60%
-36.20
Net Income Continuous Operations
-17.31
+41.80%
-29.74
-23.71%
-24.04
+33.60%
-36.20
Normalized Income
-22.72
+26.68%
-30.99
-6.93%
-28.98
+20.85%
-36.62
Net Income Common Stockholders
-17.31
+41.80%
-29.74
-23.71%
-24.04
+33.60%
-36.20
Diluted EPS
-32.15
+68.22%
-101.16
+8.45%
-110.50
+41.69%
-189.50
Basic EPS
-32.15
+68.22%
-101.16
+8.45%
-110.50
+41.69%
-189.50
Basic Average Shares
0.54
+83.14%
0.29
+34.96%
0.22
+14.11%
0.19
Diluted Average Shares
0.54
+83.14%
0.29
+34.96%
0.22
+14.11%
0.19
Diluted NI Availto Com Stockholders
-17.31
+41.80%
-29.74
-23.71%
-24.04
+33.60%
-36.20
Gain On Sale Of PPE
3.13
-59.78%
7.78
0.00
—
Line Item Trend 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total Assets
10.74
-40.12%
17.94
-50.27%
36.07
—
Current Assets
9.77
-40.14%
16.32
-52.82%
34.60
—
Cash Cash Equivalents And Short Term Investments
9.53
-13.25%
10.98
-63.32%
29.94
—
Cash And Cash Equivalents
9.53
+19.25%
7.99
-73.31%
29.94
—
Cash Equivalents
9.09
+57.00%
5.79
-80.53%
29.74
—
Cash Financial
0.44
-80.08%
2.20
+1008.00%
0.20
—
Other Short Term Investments
0.00
-100.00%
2.99
0.00
—
Receivables
0.00
-100.00%
2.92
+63.80%
1.78
—
Accounts Receivable
0.00
-100.00%
2.92
+63.80%
1.78
+12.63%
1.58
Other Receivables
—
—
—
—
Inventory
0.00
-100.00%
0.53
-44.31%
0.94
-18.72%
1.16
Raw Materials
0.00
-100.00%
0.53
+0.00%
0.53
+0.00%
0.53
Finished Goods
0.00
0.00
-100.00%
0.42
-34.20%
0.64
Prepaid Assets
0.00
-100.00%
0.82
+0.12%
0.82
-32.02%
1.20
Other Current Assets
0.24
-77.58%
1.08
-3.24%
1.12
—
Total Non Current Assets
0.97
-39.89%
1.62
+9.71%
1.47
—
Net PPE
0.92
-41.34%
1.56
+10.10%
1.42
—
Gross PPE
4.17
-6.84%
4.48
+10.66%
4.05
—
Accumulated Depreciation
-3.26
-11.62%
-2.92
-10.96%
-2.63
—
Properties
0.00
0.00
0.00
—
Buildings And Improvements
0.53
-39.81%
0.88
-0.27%
0.88
—
Machinery Furniture Equipment
1.23
+0.00%
1.23
+0.00%
1.23
—
Other Properties
1.22
+3.61%
1.18
+13.41%
1.04
—
Leases
1.20
+0.00%
1.20
+32.67%
0.90
—
Other Non Current Assets
0.06
+0.00%
0.06
+0.00%
0.06
—
Total Liabilities Net Minority Interest
10.85
-45.51%
19.92
+0.59%
19.80
—
Current Liabilities
9.66
-36.18%
15.13
-6.94%
16.26
—
Payables And Accrued Expenses
6.52
-29.57%
9.25
+9.00%
8.49
—
Payables
4.10
-4.68%
4.30
+36.29%
3.16
—
Accounts Payable
4.10
-4.68%
4.30
+36.29%
3.16
—
Current Accrued Expenses
2.41
-51.22%
4.95
-7.17%
5.33
—
Pensionand Other Post Retirement Benefit Plans Current
1.77
+13.29%
1.56
+1.16%
1.55
—
Current Debt And Capital Lease Obligation
0.43
-7.36%
0.46
-2.46%
0.47
—
Current Capital Lease Obligation
0.43
-7.36%
0.46
-2.46%
0.47
—
Other Current Liabilities
0.94
-75.52%
3.86
-32.98%
5.75
+54.62%
3.72
Total Non Current Liabilities Net Minority Interest
1.20
-75.02%
4.79
+35.12%
3.54
—
Long Term Debt And Capital Lease Obligation
0.16
-72.26%
0.59
-13.42%
0.68
—
Long Term Capital Lease Obligation
0.16
-72.26%
0.59
-13.42%
0.68
—
Other Non Current Liabilities
1.03
-50.45%
2.08
-27.19%
2.86
-54.09%
6.23
Preferred Securities Outside Stock Equity
—
0.00
0.00
0.00
Stockholders Equity
-0.11
+94.37%
-1.98
-112.17%
16.27
—
Common Stock Equity
-0.11
+94.37%
-1.98
-112.17%
16.27
—
Capital Stock
0.00
-96.89%
0.12
+25.72%
0.09
—
Common Stock
0.00
-96.92%
0.12
+25.73%
0.09
—
Preferred Stock
0.00
+0.00%
0.00
+0.00%
0.00
—
Share Issued
0.36
+53.79%
0.23
+25.73%
0.19
—
Ordinary Shares Number
0.36
+53.79%
0.23
+25.73%
0.19
—
Additional Paid In Capital
441.65
+7.74%
409.93
+1.43%
404.17
—
Retained Earnings
-441.77
-7.22%
-412.03
-6.20%
-387.99
—
Total Equity Gross Minority Interest
-0.11
+94.37%
-1.98
-112.17%
16.27
—
Total Capitalization
-0.11
+94.37%
-1.98
-112.17%
16.27
—
Working Capital
0.11
-90.59%
1.19
-93.51%
18.34
—
Invested Capital
-0.11
+94.37%
-1.98
-112.17%
16.27
—
Total Debt
0.59
-43.82%
1.05
-8.93%
1.15
—
Capital Lease Obligations
0.59
-43.82%
1.05
-8.93%
1.15
—
Net Tangible Assets
-0.11
+94.37%
-1.98
-112.17%
16.27
—
Tangible Book Value
-0.11
+94.37%
-1.98
-112.17%
16.27
—
Derivative Product Liabilities
0.00
-100.00%
2.11
—
—
Preferred Shares Number
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Preferred Stock Equity
0.00
+0.00%
0.00
+0.00%
0.00
—
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
-21.31
+32.28%
-31.46
-7.48%
-29.27
+2.18%
-29.92
Cash Flow From Continuing Operating Activities
-21.31
+32.28%
-31.46
-7.48%
-29.27
+2.18%
-29.92
Net Income From Continuing Operations
-17.31
+41.80%
-29.74
-23.71%
-24.04
+33.60%
-36.20
Depreciation Amortization Depletion
0.26
-23.64%
0.34
+17.60%
0.29
+127.63%
0.13
Depreciation And Amortization
0.26
-23.64%
0.34
+17.60%
0.29
+127.63%
0.13
Other Non Cash Items
-1.75
-602.25%
0.35
+153.17%
-0.66
-282.55%
0.36
Stock Based Compensation
1.38
-26.19%
1.87
+11.85%
1.67
-33.17%
2.51
Operating Gains Losses
-3.13
-256.07%
-0.88
+79.03%
-4.19
-2596.44%
-0.16
Gain Loss On Investment Securities
—
6.96
+250.68%
-4.62
-2071.02%
0.23
Net Foreign Currency Exchange Gain Loss
0.00
+100.08%
-0.06
-113.90%
0.43
+210.29%
-0.39
Gain Loss On Sale Of PPE
-3.13
+59.78%
-7.78
0.00
—
Change In Working Capital
-0.76
+77.73%
-3.41
-44.95%
-2.35
-168.34%
3.44
Change In Receivables
-0.03
-101.01%
2.92
+356.73%
-1.14
-469.07%
-0.20
Changes In Account Receivables
0.00
-100.00%
2.92
+356.73%
-1.14
-469.07%
-0.20
Change In Inventory
0.00
+100.00%
-1.15
-375.85%
0.42
+92.37%
0.22
Change In Prepaid Assets
-0.08
-106.84%
1.22
+3365.29%
0.04
-96.88%
1.13
Change In Payables And Accrued Expense
-0.41
+84.17%
-2.57
-444.69%
0.75
-79.58%
3.65
Change In Accrued Expense
-3.30
-39.53%
-2.37
-550.17%
-0.36
-133.79%
1.08
Change In Payable
2.90
+1536.96%
-0.20
-118.17%
1.11
-56.87%
2.57
Change In Account Payable
2.90
+1536.96%
-0.20
-118.17%
1.11
-56.87%
2.57
Change In Other Current Assets
—
—
—
—
Change In Other Current Liabilities
-0.24
+93.74%
-3.82
-58.18%
-2.41
-77.96%
-1.36
Investing Cash Flow
3.13
-74.86%
12.45
+463.32%
-3.43
-1211.08%
-0.26
Cash Flow From Continuing Investing Activities
3.13
-74.86%
12.45
+463.32%
-3.43
-1211.08%
-0.26
Net PPE Purchase And Sale
0.00
+100.00%
-0.04
+90.20%
-0.43
-66.02%
-0.26
Purchase Of PPE
0.00
+100.00%
-0.04
+90.20%
-0.43
-66.02%
-0.26
Capital Expenditure
—
-0.04
+90.20%
-0.43
-66.02%
-0.26
Net Investment Purchase And Sale
0.00
-100.00%
2.99
+200.00%
-2.99
0.00
Purchase Of Investment
—
—
-2.99
0.00
Sale Of Investment
0.00
-100.00%
2.99
0.00
—
Net Intangibles Purchase And Sale
3.13
-67.05%
9.50
0.00
—
Financing Cash Flow
11.21
-45.43%
20.55
+91.18%
10.75
+58449.90%
0.02
Cash Flow From Continuing Financing Activities
11.21
-45.43%
20.55
+91.18%
10.75
+58449.90%
0.02
Net Issuance Payments Of Debt
-0.05
+56.75%
-0.11
-5.42%
-0.10
-78.74%
-0.06
Repayment Of Debt
-0.05
+56.75%
-0.11
-5.42%
-0.10
-78.74%
-0.06
Long Term Debt Payments
-0.05
+56.75%
-0.11
-5.42%
-0.10
-78.74%
-0.06
Net Long Term Debt Issuance
-0.05
+56.75%
-0.11
-5.42%
-0.10
-78.74%
-0.06
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
7.96
-45.72%
14.67
+33.38%
11.00
0.00
Proceeds From Stock Option Exercised
3.40
-43.79%
6.05
+7750723.08%
0.00
-99.97%
0.30
Net Other Financing Charges
-0.10
-76.38%
-0.06
+61.39%
-0.15
+34.00%
-0.22
Changes In Cash
-6.96
-552.79%
1.54
+107.01%
-21.95
+27.24%
-30.17
Beginning Cash Position
9.53
+19.25%
7.99
-73.31%
29.94
-50.19%
60.10
End Cash Position
2.56
-73.09%
9.53
+19.25%
7.99
-73.31%
29.94
Free Cash Flow
-21.31
+32.37%
-31.50
-6.06%
-29.71
+1.59%
-30.18
Interest Paid Supplemental Data
0.02
-12.21%
0.02
-14.49%
0.02
-32.58%
0.03
Common Stock Issuance
7.96
-45.72%
14.67
+33.38%
11.00
0.00
Issuance Of Capital Stock
7.96
-45.72%
14.67
+33.38%
11.00
0.00
Sale Of Intangibles
3.13
-67.05%
9.50
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category